• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5

CATEGORIES

  • 9
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

4
12
14
19

PUBLISHED

0
1
2
19

PRODUCT TYPE

8
7
4

Search "Schering-Plough: Pipeline - Products - Performance - Potential" returned 19 results.

PRODUCT TITLE

Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential

“Big Pharma's Key Lifecycle Management Strategies: Maximizing the Market Potential ” provides key data, information and analysis on the key lifecycle management strategies implemented by pharmaceutical...

February 2010
FROM

Tildrakizumab (Psoriasis) - Forecast and Market Analysis to 2022

Tildrakizumab (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2–3% worldwide...

May 2013
FROM
The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact - Product Thumbnail Image

The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact

In 2010, the therapeutic cancer vaccine market witnessed several key milestones Dendreon's Provenge (sipuleucel-T) became the first product to reach the market; gaining long-awaited FDA approval for...

January 2011
FROM
Small Molecule Kinase Inhibitors - Global Strategic Business Report Small Molecule Kinase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Small Molecule Kinase Inhibitors - Global Strategic Business Report

This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb,...

July 2009
FROM
The Rheumatoid Arthritis Market: Competitive Landscape and Clinical Stage Analysis The Rheumatoid Arthritis Market: Competitive Landscape and Clinical Stage Analysis - Product Thumbnail Image

The Rheumatoid Arthritis Market: Competitive Landscape and Clinical Stage Analysis

Rheumatoid arthritis, a systemic disease characterized by inflammation of the membrane lining the joint, is one of the most common forms of arthritis Up to 50 percent of all rheumatoid arthritis patients...

May 2009
FROM

The Medicines Company (MDCO) - Financial and Strategic SWOT Analysis Review

Summary The Medicines Company (TMC) is a pharmaceutical company providing medical solutions for improving health conditions in critical care patients. The product portfolio of the company comprises...

March 2013
FROM

Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review

Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

February 2015
FROM

Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review

Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

January 2014
FROM
Dyslipidemia: Opportunities in Cardiovascular Risk Reduction Dyslipidemia: Opportunities in Cardiovascular Risk Reduction - Product Thumbnail Image

Dyslipidemia: Opportunities in Cardiovascular Risk Reduction

This report examines trends in the dyslipidemia market, which is poised for transformation with the advent of novel combination products and biopharmaceuticals Cholesterol (LDL and HDL) and triglycerides...

July 2008
Inhibitex, Inc. (INHX) - Financial and Strategic Analysis Review Inhibitex, Inc. (INHX) - Financial and Strategic Analysis Review - Product Thumbnail Image

Inhibitex, Inc. (INHX) - Financial and Strategic Analysis Review

Inhibitex, Inc. (Inhibitex) is a development stage biopharmaceutical company engaged in the research and development of innovative products for the treatment of serious infectious diseases. The pipeline...

July 2010
FROM
Colorectal Cancer (CRC) Therapeutics - Global Strategic Business Report Colorectal Cancer (CRC) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Colorectal Cancer (CRC) Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Colorectal Cancer Therapeutics in US$ Million The major product segments analyzed are Cytotoxic Therapies (5-FU (Fluorouracil), Camptosar (Irinotecan),...

October 2006
FROM

Pre-Filled Syringes Market (2nd Edition), 2014 - 2024

Prefilled syringes are gaining strong acceptance in the market as drug delivery systems for injectable drugs. They have become a preferred device for parenteral administration of drugs, mainly used...

July 2014
FROM
Credit Trends: Downgrade Potential Across Credit Grades And Sectors Feb 06 Credit Trends: Downgrade Potential Across Credit Grades And Sectors Feb 06 - Product Thumbnail Image

Credit Trends: Downgrade Potential Across Credit Grades And Sectors Feb 06

Abstract A total of 636 entities appeared at risk globally of potential downgrades as of Feb. 22, 2006, compared with 620 in mid-January. Almost 87% of those at risk of downgrades were located either...

February 2006
Credit Trends: Downgrade Potential Across Credit Grades And Sectors Nov 05 Credit Trends: Downgrade Potential Across Credit Grades And Sectors Nov 05 - Product Thumbnail Image

Credit Trends: Downgrade Potential Across Credit Grades And Sectors Nov 05

Abstract A total of 656 entities appeared at risk globally of potential downgrades as of Nov. 21, 2005, compared with 649 in mid-September. 87% of those at risk of downgrades were located either in...

November 2005
Credit Trends: Downgrade Potential Across Credit Grades And Sectors Dec 05 Credit Trends: Downgrade Potential Across Credit Grades And Sectors Dec 05 - Product Thumbnail Image

Credit Trends: Downgrade Potential Across Credit Grades And Sectors Dec 05

Abstract A total of 632 entities appeared at risk globally of potential downgrades as of Dec. 21, 2005, compared with 656 in mid-November. 87% of those at risk of downgrades were located either in...

December 2005
Credit Trends: Downgrade Potential Across Credit Grades And Sectors Oct 05 Credit Trends: Downgrade Potential Across Credit Grades And Sectors Oct 05 - Product Thumbnail Image

Credit Trends: Downgrade Potential Across Credit Grades And Sectors Oct 05

Abstract A total of 649 entities appeared at risk globally of potential downgrades as of Oct. 26, 2005, compared with 632 in mid-September. 88% of those at risk of downgrades were located either in...

October 2005
Credit Trends: Downgrade Potential Across Credit Grades And Sectors Sep 05 Credit Trends: Downgrade Potential Across Credit Grades And Sectors Sep 05 - Product Thumbnail Image

Credit Trends: Downgrade Potential Across Credit Grades And Sectors Sep 05

Abstract A total of 632 entities appeared at risk globally of potential downgrades in mid-September 2005. This is the first publication in a series of reports that will monitor issuers at risk of downgrades...

September 2005
Credit Trends: Downgrade Potential Across Credit Grades And Sectors Mar 06 Credit Trends: Downgrade Potential Across Credit Grades And Sectors Mar 06 - Product Thumbnail Image

Credit Trends: Downgrade Potential Across Credit Grades And Sectors Mar 06

Abstract This month, we note the following key takeaways: The number of entities at risk of potential downgrades jumped to a high of 659 in mid-March, compared with 636 in mid-February. This count...

March 2006
Credit Trends: Downgrade Potential Across Credit Grades And Sectors Jan 06 Credit Trends: Downgrade Potential Across Credit Grades And Sectors Jan 06 - Product Thumbnail Image

Credit Trends: Downgrade Potential Across Credit Grades And Sectors Jan 06

Abstract A total of 620 entities appeared at risk globally of potential downgrades as of Jan. 22, 2006, compared with 632 in mid-December. Almost 87% of those at risk of downgrades were located either...

January 2006
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.